Nvidias Blockbuster Earnings Reveal 200 Billion Edge Computing Opportunity Amid China Market Shift
Nuclear Energy Sector Attracts LongTerm Investor Interest Amid Global Clean Energy Transition
Imagine Partners with Bojangles to Redefine InRestaurant Brand Experience Nationwide
Shell SHEL Upgraded to Buy Following Transaction with ARC Resources
Broadcom Meta Tech Giants Launch 125 Million Semiconductor Research Hub at UCLA
Taiwan Chip Stocks Surge on Nvidias 150B Spending Plans Chinas Cambricon Slips
UNP Q1 2026 Earnings EPS Beats Estimates Amid Strong Operational Performance
RYDE Q2 2025 Earnings EPS Misses Estimates Shares Surge 947
Northfield Bancorp Inc NFBK Q1 2026 Earnings EPS Beat Sends Shares Slightly Lower Amid Cautious Outlook
CDRE Q1 2026 Earnings EPS Miss Amid Operational Challenges Stock Rises 158
MITP Q1 2026 Earnings EPS Beats Estimates Amid Steady Mortgage Operations
DDL Q4 2025 Earnings Profitability Milestone Despite Mixed Market Signals
Nuwellis Inc NUWE Pushes Past Key Support Tests Resistance at 110
Exagen Inc XGN Inches Lower as Shares Test Key Support Near 405
BioMarin Pharmaceutical BMRN Edges Higher as Biotech Sector Shows Resilience
Veritone VERI Edges Higher as Stock Consolidates Near Key Support
LMP Capital and Income Fund SCD Narrows Slightly Holding Near Resistance
Plus500 Reports 11 Quarterly Revenue Growth Reaffirms FullYear Outlook
OPTU Q1 2026 Earnings A Staggering EPS Miss Rattles Investors
Northpointe Bancshares NPB Nudges Higher Near Support as Consolidation Continues
ORIO Q1 2026 Earnings NarrowerThanExpected Loss Signals Improved Cost Discipline
Turkcell Q4 2025 Earnings EPS of 440 Reported Amid Stock Pullback
Runway Growth Finance Corp RWAY Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady
DDS Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Retail Environment
Sonida Senior Living Inc Q1 2026 Earnings WiderThanExpected Loss Weighs on Shares
ALAB Q1 2026 Earnings EPS Beats Estimates Revenue Not Disclosed
Skye Bioscience Q1 2026 Earnings Wider Loss Than Expected as DevelopmentStage Biotech Continues Cash Burn